• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM ALPHA-FETOPROTEIN (AFP); ALPHA-FETOPROTEIN IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM ALPHA-FETOPROTEIN (AFP); ALPHA-FETOPROTEIN IMMUNOASSAY Back to Search Results
Model Number N/A
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/08/2020
Event Type  malfunction  
Manufacturer Narrative
Siemens healthcare diagnostics has completed the investigation into one initially discordant high atellica im alpha-fetoprotein (afp) result with reagent lot 221 that repeated as negative with reagent lot 224.There is no sample left for siemens to perform additional testing.Two months of quality control data was reviewed, and no fliers were observed.Calibrations were acceptable and no errors were found in the instrument error log.Siemens in house data was reviewed for both reagent lots 221 and 224 and no fliers were observed.Siemens cannot rule out preanalytical handling of the sample.Customer is running without any further issue.No product nonconformance was identified.No further investigation required.(b)(4).
 
Event Description
A customer obtained an elevated atellica im alpha-fetoprotein (afp) initial result for one patient.The result was reported to the physician.The complaint record indicated that the physician did not question the result.The customer stated that there was no sample integrity issue observed when the sample was visually checked.There was no bias, trend or shift observed in quality control data.The patient went to a different laboratory (non-customer site) for testing with an alternate method.The alternate method result (5 ug/l) was considered to be in normal range.The patient's sample from the non-customer laboratory was sent to the customer site and tested with atellica im afp, using a different reagent lot than was used to test the initial sample.The results were lower than the initial result.Patient treatment was not prescribed or altered.There was no report of adverse health consequences due to the discordant afp result.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM ALPHA-FETOPROTEIN (AFP)
Type of Device
ALPHA-FETOPROTEIN IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
333 coney street
east walpole MA 02032
Manufacturer Contact
stacy loukos
333 coney street
east walpole, MA 02032
5084635000
MDR Report Key10518781
MDR Text Key228172616
Report Number1219913-2020-00237
Device Sequence Number1
Product Code LOK
Combination Product (y/n)N
Reporter Country CodeSN
PMA/PMN Number
P930036
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 09/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/10/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/10/2021
Device Model NumberN/A
Device Catalogue Number10995441
Device Lot Number221
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/17/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-